Calliditas Therapeutics (Calliditas), an Asahi Kasei company, announced today that new data was presented at the 62nd European Renal Association Congress (ERA Congress), which took place in Vienna, ...

Measles is on the rise in Canada and poses serious risks to pregnant people and their newborns, yet discussion about how to ...

Pregnant women are "bearing the burden" of the huge measles outbreak in Canada, Dr. Catherine Varner, an expert on emergency ...

Panelists discuss how the management of immunoglobulin A (IgA) nephropathy is undergoing a transformative shift from symptom control to targeted disease modification, with emerging therapies offering ...

Panelists discuss how economic considerations in immunoglobulin A (IgA) nephropathy medication management vary dramatically across chronic kidney disease (CKD) stages, with early intervention costs ...

Ontario's chief medical officer of health says six infants have been born with congenital measles since an outbreak began ...

The following is a summary of “Burden of corticosteroid therapy in patients with immunoglobulin A nephropathy (IgAN): a ...

A novel immunoglobulin A nephropathy (IgAN) drug cut proteinuria in half, according to interim findings from the ongoing ...

The novel selective antibody sibeprenlimab reduced proteinuria more than any prior drug for IgA nephropathy, with excellent ...

A subanalysis of the NeflgArd study shows benefits in eGFR and urine protein-creatinine ratio at baseline and across ...

Otsuka's investigational antibody sibeprenlimab approximately halved levels of this key biomarker in patients with ...